Novartis buys cancer drug unit, gets generics boost

ZURICH (Reuters) – Novartis AG is buying the injectable generic cancer drugs business of Austria’s EBEWE Pharma and may pursue other similar deals as it fleshes out a planned diversification away from brand-name treatments.

Leave a Reply